Nearly 1 billion people likely to live with osteoarthritis by 2050, study estimates

A new study projects nearly 1 billion people will be living with osteoarthritis, the most common form of arthritis, by 2050. Currently, 15% of individuals aged 30 and older experience osteoarthritis.

Breakthrough in pancreatic cancer treatment: Inhibiting specific enzymes slows tumor progression

Study demonstrates that inhibiting stromal class I histone deacetylases (HDACs) can effectively slow down pancreatic cancer progression, shedding light on a new therapeutic approach targeting

December 11, 2023

Neurocrine reports a second PhIII success in congenital adrenal hyperplasia, this time in children

Neurocrine Biosciences said its treatment for congenital adrenal hyperplasia (CAH) — a genetic disorder that causes hormone imbalance — helped reduce the daily dose of

October 6, 2023

Researchers find 41 new genetic regions linked to disc herniations

Lumbar disc herniation is one of the most common structural changes in the lower back and the most common cause of radiating pain, or sciatica,

November 7, 2024

Supercharge Your Portfolio with Future Health Stocks!

Join us for Profitable Insights & Expert Tips!

With expert analysis, comprehensive market coverage, and actionable insights, our newsletter equips you with the knowledge & tools necessary to make informed decisions & maximize your potential returns in the dynamic world of future health stocks.